Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo

INTRODUCTION: Bone metastasis remains incurable with treatment restricted to palliative care. Cabozantinib (CBZ) is targeted against multiple receptor tyrosine kinases involved in tumour pathobiology, including hepatocyte growth factor receptor (MET) and vascular endothelial growth factor receptor 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Marie-Therese, Hunter, Keith D., Robinson, Simon P., Graham, Timothy J., Corey, Eva, Dear, T. Neil, Hughes, Russell, Brown, Nicola J., Holen, Ingunn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Original Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768060/
https://www.ncbi.nlm.nih.gov/pubmed/26279137
http://dx.doi.org/10.1016/j.bone.2015.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768060/
https://www.ncbi.nlm.nih.gov/pubmed/26279137
http://dx.doi.org/10.1016/j.bone.2015.08.003

Ejemplares similares